Masimo Announces CE Marking for Pediatric O3™ Regional Oximetry
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Wall St set for higher open as AI stocks rise, oil slides
- Oil prices slide to 11-day low on hopes of US-Iran diplomacy, Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- Streamflation drives 39% of Americans to cancel streaming in 6 months
- Wall St set for higher open as AI stocks rise, oil slides
Wedbush Raises Price Target on Masimo Corp. (MASI) Following 2Q Beat and Raise
August 4, 2016 9:52 AM EDTWedbush reiterated an Outperform rating on Masimo Corp. (NASDAQ: MASI), and raised the price target to $63.00 (from $60.00), following the company's 2Q earnings report. Product revenue of $165 million was ~$6 million ahead of estimates. Adjusted EPS of $0.45 beat estimates by $0.04. Masimo now expects product revenue of $658... More
Piper Jaffray Raises Price Target on Masimo Corp. (MASI) Following the Company's 2Q Earnings Report
August 4, 2016 8:54 AM EDTPiper Jaffray reiterated an Overweight rating on Masimo Corp. (NASDAQ: MASI), and raised the price target to $55.00 (from $52.00), following the company's 2Q earnings report. Revenue increased 10.9% yoy to $172.6M, above consensus' $166.0M estimate. GAAP EPS of $0.57 was also above the Street's $0.41.
Analyst William Quirk commented, "Masimo... More
